/
Navigation
C
Chronicles
Browse all articles
C
E
Explore
Semantic exploration
E
R
Research
Entity momentum
R
N
Nexus
Correlations & relationships
N
~
Story Arc
Topic evolution
S
Drift Map
Semantic trajectory animation
D
P
Posts
Analysis & commentary
P
Browse
@
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
?
Concept Search
Semantic similarity search
!
High Impact Stories
Top coverage by position
+
Sentiment Analysis
Positive/negative coverage
*
Anomaly Detection
Unusual coverage patterns
Analysis
vs
Rivalry Report
Compare two entities head-to-head
/\
Semantic Pivots
Narrative discontinuities
!!
Crisis Response
Event recovery patterns
Connected
Nav: C E R N
Search: /
Command: ⌘K
Embeddings: large
VOICE ARCHIVE

Blake Byers

@byersblake
3 posts
2026-01-22
Congrats Daniel and the @EvidenceOpen team. Nearly every doctor I know has OE on their home screen. Incredible product execution and strategic position.
2026-01-22 View on X
CNBC

OpenEvidence, which is building “ChatGPT for doctors”, raised $250M led by Thrive and DST at a $12B valuation, up from $6B in October and $1B in February 2025

2025-12-15
Congrats @jackdent and @joshim5 on the $130M Series B! Compressing multi year campaigns into weeks. Time to start treating some diseases. [image]
2025-12-15 View on X
Bloomberg

AI drug discovery startup Chai Discovery raised a $130M Series B led by Oak HC/FT and General Catalyst at a $1.3B valuation, taking its total funding to $225M

Chai Discovery, an artificial intelligence drug-discovery company backed by OpenAI, has raised $130 million to build a “computer-aided design suite” for molecules.

2023-05-26
We used to sit around our house in 2011 talking about paths to the first high bandwidth BMI device. Many of the people in that house would go on to found Neuralink. An amazing mile marker — now on to serving patients. Congrats @djseo8 @shivon @JosephODohert11 @maxhodak_ and team! https://twitter.com/...
2023-05-26 View on X
Reuters

Neuralink says the company received US FDA approval to launch its first-in-human clinical study of brain implants and plans to offer more details soon

Elon Musk's brain-implant company Neuralink on Thursday said it had received U.S. Food and Drug Administration's (FDA) approval to launch first-in-human clinical study.